Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 18,881 followers.

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma https://t.co/pS2p8JaCR1

21 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell r…

08 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell r…

08 Oct 2023

Reply Repost Favourite

New research: Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma: Extrarenal clear cell renal cell carcinoma (eccRCC) is a rare type of RCC that arises in areas other… #oncology htt

08 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.